MXPA01010540A - Proteina homologa zacrp2 relacionada al complemento de adipocitos. - Google Patents

Proteina homologa zacrp2 relacionada al complemento de adipocitos.

Info

Publication number
MXPA01010540A
MXPA01010540A MXPA01010540A MXPA01010540A MXPA01010540A MX PA01010540 A MXPA01010540 A MX PA01010540A MX PA01010540 A MXPA01010540 A MX PA01010540A MX PA01010540 A MXPA01010540 A MX PA01010540A MX PA01010540 A MXPA01010540 A MX PA01010540A
Authority
MX
Mexico
Prior art keywords
polypeptide
amino acid
seq
sequence
zacrp2
Prior art date
Application number
MXPA01010540A
Other languages
English (en)
Spanish (es)
Inventor
Christopher S Piddington
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Publication of MXPA01010540A publication Critical patent/MXPA01010540A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
MXPA01010540A 1999-04-20 2000-04-19 Proteina homologa zacrp2 relacionada al complemento de adipocitos. MXPA01010540A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29507299A 1999-04-20 1999-04-20
PCT/US2000/010452 WO2000063376A1 (fr) 1999-04-20 2000-04-19 Zacrp2 homologues proteiques apparentes au complement adipocytaire

Publications (1)

Publication Number Publication Date
MXPA01010540A true MXPA01010540A (es) 2002-06-04

Family

ID=23136091

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA01010540A MXPA01010540A (es) 1999-04-20 2000-04-19 Proteina homologa zacrp2 relacionada al complemento de adipocitos.

Country Status (9)

Country Link
EP (1) EP1171599A1 (fr)
JP (1) JP2002541846A (fr)
AU (1) AU4468600A (fr)
CA (1) CA2370602A1 (fr)
IL (1) IL146011A0 (fr)
MX (1) MXPA01010540A (fr)
NO (1) NO20015114L (fr)
WO (1) WO2000063376A1 (fr)
ZA (1) ZA200108438B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU2002246535A1 (en) 2000-11-29 2002-08-06 Zymogenetics, Inc. Adipocyte complement related protein zacrp13
AU2002216671A1 (en) * 2000-11-29 2002-06-11 Zymogenetics Inc. Adipocyte complement related protein zacrp12

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869330A (en) * 1995-06-05 1999-02-09 Whitehead Institute For Biomedical Research DNA encoding a novel serum protein produced exclusively in adipocytes
FR2767135B1 (fr) * 1997-08-06 2002-07-12 Genset Sa Recepteur complexe lsr, activite, clonage, et application au diagnostic, a la prevention et/ou au traitement de d'obesite et des risques ou complications associes
NZ507728A (en) * 1998-04-29 2002-06-28 Genesis Res & Dev Corp Ltd Information from a cDNA library created from keratinocytes, dermal papilla, neonatal foreskin fibroblast or embryonic skin cells is used to treating cancer, angiogenesis, skin inflammation, inflammatory diseases or stimulating keratinocyte growth
EP1085897A4 (fr) * 1998-05-21 2003-03-12 Smithkline Beecham Corp Acrp30r1l, homologue de acrp30 (proteine associee a un complement de l'adipocyte 30 kd)

Also Published As

Publication number Publication date
NO20015114D0 (no) 2001-10-19
JP2002541846A (ja) 2002-12-10
ZA200108438B (en) 2002-08-28
CA2370602A1 (fr) 2000-10-26
WO2000063376A1 (fr) 2000-10-26
NO20015114L (no) 2001-12-19
IL146011A0 (en) 2002-07-25
AU4468600A (en) 2000-11-02
EP1171599A1 (fr) 2002-01-16

Similar Documents

Publication Publication Date Title
US20060040360A1 (en) Adipocyte complement related protein homolog zacrp7
JP3762220B2 (ja) 脂肪細胞特異的タンパク質分子
US20060034866A1 (en) Adipocyte complement related protein homolog zacrp3
JP3754299B2 (ja) 脂肪細胞補体関連タンパク質同族体ｚａｃｒｐ３
US7208578B2 (en) Adipocyte complement related protein homolog zacrp2
MXPA01010540A (es) Proteina homologa zacrp2 relacionada al complemento de adipocitos.
US20030170781A1 (en) Secreted protein zacrp4
WO2000073446A2 (fr) Zacpr6 homologue d'une proteine se rapportant a un complement adipocytaire
WO2000073444A1 (fr) Homologue zacrp5 de proteine apparente aux complements adipocytes
US6692748B2 (en) Adipocyte complement related protein zacrp3x2 and nucleic acids encoding zacrp3x2
US20050042719A1 (en) Adipocyte complement related protein homolog zacrp5
US20020155546A1 (en) Adipocyte complement related protein ZACRP12
US20020160474A1 (en) Adipocyte complement related protein zacrp11
CA2378951A1 (fr) Proteine zacrp4 secretee
MXPA01003766A (en) Follistatin-related protein zfsta2